Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
PUT
GXO Logistics
GXO
$5.38B
| $489K | ﹤0.01% |
12,500
-600
| -5% | -$25.1K |
|
2302
Intellia Therapeutics
NTLA
$1.85B
| $485K | ﹤0.01% |
+68,277
| New | +$690K |
|
2303
Oil-Dri
ODC
$1.33B
| $485K | ﹤0.01% |
+10,568
| New | +$466K |
|
2304
Green Plains
GPRE
$1.03B
| $485K | ﹤0.01% |
99,961
-162,918
| -62% | -$1.17M |
|
2305
CALL
Republic Services
RSG
$68.1B
| $484K | ﹤0.01% |
2,000
-300
| -13% | -$67.3K |
|
|
HUT
2306
CALL
Hut 8
HUT
$10.1B
| $482K | ﹤0.01% |
+41,500
| New | +$766K |
|
2307
Ovintiv
OVV
$18B
| $480K | ﹤0.01% |
11,205
-18,873
| -63% | -$806K |
|
|
MAGN
2308
Magnera Corp
MAGN
$435M
| $480K | ﹤0.01% |
26,407
-185,411
| -88% | -$3.6M |
|
2309
PUT
Public Storage
PSA
$60B
| $479K | ﹤0.01% |
+1,600
| New | +$479K |
|
|
SNV
2310
PUT
DELISTED
Synovus
SNV
| $477K | ﹤0.01% |
10,200
-800
| -7% | -$41.3K |
|
2311
PUT
MarketAxess Holdings
MKTX
$5.72B
| $476K | ﹤0.01% |
+2,200
| New | +$462K |
|
2312
Bain Capital Specialty
BCSF
$784M
| $475K | ﹤0.01% |
+28,588
| New | +$504K |
|
2313
CALL
Acuity Brands
AYI
$10.2B
| $474K | ﹤0.01% |
1,800
+700
| +64% | +$212K |
|
2314
CALL
Shift4
FOUR
$3.95B
| $474K | ﹤0.01% |
5,800
+1,200
| +26% | +$124K |
|
2315
Boston Omaha
BOC
$422M
| $474K | ﹤0.01% |
+32,502
| New | +$467K |
|
2316
PUT
Solventum
SOLV
$15.4B
| $471K | ﹤0.01% |
+6,200
| New | +$462K |
|
2317
CALL
SoundHound AI
SOUN
$3.12B
| $471K | ﹤0.01% |
+58,000
| New | +$723K |
|
2318
PUT
Expedia Group
EXPE
$40.4B
| $471K | ﹤0.01% |
+2,800
| New | +$510K |
|
2319
PUT
Rapid7
RPD
$812M
| $469K | ﹤0.01% |
17,700
+8,300
| +88% | +$282K |
|
2320
CALL
Ares Management
ARES
$31B
| $469K | ﹤0.01% |
+3,200
| New | +$553K |
|
2321
Kulicke & Soffa
KLIC
$4.41B
| $468K | ﹤0.01% |
14,201
+4,309
| +44% | +$177K |
|
2322
Vanguard FTSE Europe ETF
VGK
$31.3B
| $467K | ﹤0.01% |
6,652
-12,060
| -64% | -$831K |
|
2323
PUT
Yeti Holdings
YETI
$3.12B
| $467K | ﹤0.01% |
14,100
+600
| +4% | +$21.7K |
|
|
2324
PUT
Ovintiv
OVV
$18B
| $467K | ﹤0.01% |
10,900
-700
| -6% | -$29.9K |
|
2325
CALL
PTC
PTC
$16.5B
| $465K | ﹤0.01% |
+3,000
| New | +$516K |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.